Login
$TENX
$1.48 +$0.00 (0.0%) After hours

$TENX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13G/A
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Completed Statistical Analyses of LEVEL Yielded a Predictive Enrichment Strategy Being Applied in Amended LEVEL-2 Protocol

27 Oct 2026 SCHEDULE 13G/A
21 Oct 2026 Form 4: ADAR1 Capital Management, Llc, 10% owner and 1 other

Bought 336,528 shares ($507K) · Bought 254,342 shares ($406K) · Bought 331,979 shares ($551K)

15 Oct 2026 SCHEDULE 13G/A
13 Oct 2026 SCHEDULE 13G/A
09 Oct 2026 SCHEDULE 13G/A
08 Oct 2026 8-K: Other Events

Forward-Looking Statements Disclaimers Except for historical information, all of the statements, expectations and assumptions contained in this presentation are forward-looking statements. These forward-looking statements include, but ar...

17 Sep 2026 Form 4: Doogan Declan, Director

Bought 53,000 shares ($102K)

15 Sep 2026 Form 4: Giordano Christopher Thomas, Director

Bought 6,000 shares ($11.3K) · Bought 4,850 shares ($8.84K)

15 Sep 2026 Form 4: Staab Thomas R Ii, Chief Financial Officer

Bought 5,675 shares ($11K)

11 Sep 2026 SCHEDULE 13G/A
09 Sep 2026 8-K: Regulation FD Disclosure

LEVEL Clinical Trial Results September 09, 2026 Exhibit 99.1

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support